MRNA vs SRTAW · rev $145.0M vs rev $248.7M
Moderna Inc (MRNA) versus Strata Critical Medical, Inc. (SRTAW) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
MRNA currently screens at market cap $24.52B. SRTAW currently screens at market cap $0.
Not investment advice. Open the MRNA and SRTAW stock pages for the full models.
Not investment advice.